Control the platelets, control the disease: A novel cystic fibrosis hypothesis

Cystic fibrosis (CF) is a life-threatening disease associated with a viscous mucus that predisposes CF patients to chronic neutrophilic lung inflammation, often leading to respiratory failure. In a recent article published in the Journal of Clinical Investigation, Ortiz-Munoz et al1 demonstrate that platelets regulate the hyperinflammatory response and suggest that they may be to key to controlling the inflammation in CF patients.

• Publication year

  2020

• Venue

  Journal of Thrombosis and Haemostasis

• Publication date

  2020-05-28

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1111/jth.14868PMID 32468670PMCID PMC7872297
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Cystic fibrosis transmembrane conductance regulator dysfunction in platelets drives lung hyperinflammation.

  2020cited by this paper
• Impact of CFTR modulator use on outcomes in people with severe cystic fibrosis lung disease

  2020cited by this paper
• Lung transplantation for cystic fibrosis.

  2020cited by this paper
• Elexacaftor-Tezacaftor-Ivacaftor for Cystic Fibrosis with a Single Phe508del Allele.

  2019cited by this paper
• Efficacy and safety of the elexacaftor plus tezacaftor plus ivacaftor combination regimen in people with cystic fibrosis homozygous for the F508del mutation: a double-blind, randomised, phase 3 trial.

  2019cited by this paper
• Progression of Cystic Fibrosis Lung Disease from Childhood to Adulthood: Neutrophils, Neutrophil Extracellular Trap (NET) Formation, and NET Degradation

  2019cited by this paper
• Dysregulated Calcium Homeostasis in Cystic Fibrosis Neutrophils Leads to Deficient Antimicrobial Responses

  2018cited by this paper
• Ataluren in cystic fibrosis: development, clinical studies and where are we now?

  2017cited by this paper
• Gene therapy for Cystic Fibrosis: Improved delivery techniques and conditioning with lysophosphatidylcholine enhance lentiviral gene transfer in mouse lung airways

  2017cited by this paper
• Current and future treatment options for cystic fibrosis lung disease: latest evidence and clinical implications

  2016cited by this paper
• Cystic fibrosis

  2016cited by this paper
• Origins of cystic fibrosis lung disease.

  2015cited by this paper
• A Critical Role for the Transient Receptor Potential Channel Type 6 in Human Platelet Activation

  2015cited by this paper
• Risk factors for bronchiectasis in children with cystic fibrosis.

  2013cited by this paper
• Important Role of Platelets in Modulating Endotoxin-Induced Lung Inflammation in CFTR-Deficient Mice

  2013cited by this paper
• PPARγ as a therapeutic target in cystic fibrosis.

  2012cited by this paper
• Transient receptor potential canonical channel 6 links Ca2+ mishandling to cystic fibrosis transmembrane conductance regulator channel dysfunction in cystic fibrosis.

  2011cited by this paper
• Cystic fibrosis transmembrane conductance regulator (CFTR) expression in human platelets: impact on mediators and mechanisms of the inflammatory response

  2010cited by this paper
• Cystic Fibrosis

  2009cited by this paper
• CFTR Is a Negative Regulator of NFκB Mediated Innate Immune Response

  2009cited by this paper
• Registry of the International Society for Heart and Lung Transplantation: twenty-fifth official adult heart transplant report--2008.

  2008cited by this paper
• Consensus on the use and interpretation of cystic fibrosis mutation analysis in clinical practice.

  2008cited by this paper
• The role of chloride anion and CFTR in killing of Pseudomonas aeruginosa by normal and CF neutrophils

  2008cited by this paper
• Lung transplantation and survival in children with cystic fibrosis.

  2007cited by this paper
• CFTR inhibition mimics the cystic fibrosis inflammatory profile.

  2007cited by this paper
• CFTR Expression in human neutrophils and the phagolysosomal chlorination defect in cystic fibrosis.

  2006cited by this paper
• Cystic fibrosis.

  2005cited by this paper
• Platelet activation in cystic fibrosis.

  2005cited by this paper
• Lung inflammation as a therapeutic target in cystic fibrosis.

  2004cited by this paper
• Cystic fibrosis

  2003cited by this paper
• Bacterial stimulation of epithelial G-CSF and GM-CSF expression promotes PMN survival in CF airways.

  2002cited by this paper
• Cystic Fibrosis Transmembrane Conductance Regulator Inverts Protein Kinase A-mediated Regulation of Epithelial Sodium Channel Single Channel Kinetics*

  1997cited by this paper
• Early pulmonary inflammation in infants with cystic fibrosis.

  1995cited by this paper

• Mesenteric Vein Thrombosis (MVT) as the Cause of Abdominal Pain in Pediatric Cystic Fibrosis (CF): A Case Report

  2024cites this paper
• The enigmatic nature of the triggering receptor expressed in myeloid cells -1 (TLT- 1)

  2021cites this paper